-
公开(公告)号:US20080199490A1
公开(公告)日:2008-08-21
申请号:US11917569
申请日:2006-06-23
申请人: Ralph Leon Biemans , Dominique Boutriau , Carine Capiau , Philippe Denoel , Pierre Duvivier , Jan Poolman
发明人: Ralph Leon Biemans , Dominique Boutriau , Carine Capiau , Philippe Denoel , Pierre Duvivier , Jan Poolman
IPC分类号: A61K39/102 , A61K39/116
CPC分类号: A61K39/385 , A61K39/0017 , A61K39/0018 , A61K39/05 , A61K39/08 , A61K39/092 , A61K39/095 , A61K39/099 , A61K39/102 , A61K39/116 , A61K39/12 , A61K39/145 , A61K39/292 , A61K2039/545 , A61K2039/55 , A61K2039/575 , A61K2039/6037 , A61K2039/62 , A61K2039/627 , A61K2039/70 , C07H3/00 , C12N7/00 , C12N2730/10134 , C12N2760/16234 , C12N2760/16271 , C12N2770/32634 , Y02A50/466 , Y02A50/472 , Y02A50/484
摘要: The present application discloses an immunogenic composition comprising a Hib saccharide conjugate and at least two further bacterial saccharide conjugates wherein the Hib conjugate is present in a lower saccharide dose than the mean saccharide dose of all the at least two further bacterial saccharide conjugates.
摘要翻译: 本申请公开了包含Hib糖结合物和至少两种其它细菌糖共轭物的免疫原性组合物,其中Hib缀合物以比所有至少两种其它细菌糖共轭物的平均糖剂量低的糖类剂量存在。
-
2.
公开(公告)号:US5578308A
公开(公告)日:1996-11-26
申请号:US338361
申请日:1994-11-14
申请人: Carine Capiau , Jean Petre
发明人: Carine Capiau , Jean Petre
IPC分类号: A61K39/10 , A61K39/385 , C07K14/235 , C07K17/00
CPC分类号: A61K39/099
摘要: A detoxified B. pertussis toxin or antigenic preparation is described, which is characterized by stability to reversion to toxicity upon storage at 4.degree.-8.degree. C. and at temperatures above 23.degree. C. Also provided are methods for producing detoxified pertussis toxin and vaccines containing same.
摘要翻译: 描述了一种解毒的百日咳百日咳毒素或抗原制剂,其特征在于在4℃-8℃和高于23℃的温度下储存时的稳定性恢复为毒性。还提供了产生解毒的百日咳毒素和疫苗的方法 包含相同。
-
公开(公告)号:US09233151B2
公开(公告)日:2016-01-12
申请号:US13439829
申请日:2012-04-04
IPC分类号: A61K39/095 , A61K39/116 , A61K39/02 , A61K47/48 , A61K39/29 , A61K39/102 , A61K39/08 , A61K39/05 , C07H3/00 , A61K39/385 , A61K39/00
CPC分类号: A61K39/102 , A61K2039/545 , A61K2039/6037 , Y02A50/466 , Y02A50/484
摘要: A multi-valent vaccine composition is described comprising a conjugate of the capsular polysaccharide of H. influenzae b not adsorbed onto an aluminum adjuvant salt, and two or more further bacterial polysaccharides. A multi-valent vaccine composition is also described comprising a whole-cell pertussis component, tetanus toxoid, diphtheria toxoid, Hepatitis B surface antigen, a conjugate of the capsular polysaccharide of H. influenzae b, and a conjugate of a capsular polysaccharide of N. meningitidis type A or C (or both). Furthermore, a multi-valent vaccine composition is described comprising a whole-cell pertussis component, tetanus toxoid, diphtheria toxoid, and a low dose of a conjugate of the capsular polysaccharide of H. influenzae b.
摘要翻译: 描述了一种多价疫苗组合物,其包含未吸附到铝佐剂盐上的流感嗜血杆菌b的荚膜多糖的缀合物和两种或更多种其它细菌多糖。 还描述了一种多价疫苗组合物,其包括全细胞百日咳组分,破伤风类毒素,白喉类毒素,乙型肝炎表面抗原,流感嗜血杆菌b的荚膜多糖的缀合物和荚膜多糖的缀合物。 A型或C型脑膜炎(或两者)。 此外,描述了包含全细胞百日咳组分,破伤风类毒素,白喉类毒素和低剂量流感嗜血杆菌b的荚膜多糖的缀合物的多价疫苗组合物。
-
公开(公告)号:US20090136541A1
公开(公告)日:2009-05-28
申请号:US11917702
申请日:2006-06-23
申请人: Ralph Leon Biemans , Dominique Boutriau , Carine Capiau , Philippe Denoel , Pierre Duvivier , Jan Poolman
发明人: Ralph Leon Biemans , Dominique Boutriau , Carine Capiau , Philippe Denoel , Pierre Duvivier , Jan Poolman
IPC分类号: A61K39/385 , A61P31/04
CPC分类号: A61K39/385 , A61K39/0017 , A61K39/0018 , A61K39/05 , A61K39/08 , A61K39/092 , A61K39/095 , A61K39/099 , A61K39/102 , A61K39/116 , A61K39/12 , A61K39/145 , A61K39/292 , A61K2039/545 , A61K2039/55 , A61K2039/575 , A61K2039/6037 , A61K2039/62 , A61K2039/627 , A61K2039/70 , C07H3/00 , C12N7/00 , C12N2730/10134 , C12N2760/16234 , C12N2760/16271 , C12N2770/32634 , Y02A50/466 , Y02A50/472 , Y02A50/484
摘要: The present application discloses an immunogenic composition comprising at least 2 different N. meningitidis capsular saccharides, wherein one or more is/are selected from a first group consisting of MenA, MenC, MenY and MenW which is/are conjugated to a protein carrier(s) wherein the saccharide:protein ratio (w/w) is between 1:2-1:5, and one or more different saccharides is/are selected from a second group consisting of MenA, MenC, MenY and MenW which is/are conjugated to a protein carrier(s) wherein the saccharide:protein ratio (w/w) is between 5:1-1:1.99.
摘要翻译: 本申请公开了一种免疫原性组合物,其包含至少2种不同的脑膜炎奈瑟氏球菌荚膜糖,其中一种或多种选自MenA,MenC,MenY和MenW组成的第一组,其与蛋白质载体(s ),其中糖:蛋白质比(w / w)为1:2-1:5,并且一种或多种不同的糖选自MenA,MenC,MenY和MenW组成的第二组,其为共轭的 涉及蛋白质载体,其中糖:蛋白质比(w / w)在5:1-1:1.99之间。
-
公开(公告)号:US20060093626A1
公开(公告)日:2006-05-04
申请号:US11240193
申请日:2005-09-30
申请人: Carine Capiau , Marguerite Deschamps , Pierre Desmons , Craig Laferriere , Jan Poolman , Jean-Paul Prieels
发明人: Carine Capiau , Marguerite Deschamps , Pierre Desmons , Craig Laferriere , Jan Poolman , Jean-Paul Prieels
IPC分类号: A61K39/09
CPC分类号: A61K39/155 , A61K39/092 , A61K39/095 , A61K39/102 , A61K39/12 , A61K47/646 , A61K2039/55505 , A61K2039/55572 , A61K2039/6037 , A61K2039/6068 , A61K2039/6075 , A61K2039/70 , Y02A50/414 , Y02A50/484 , Y10S424/831
摘要: The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular the present invention relates to specific advantageous pneumococcal polysaccharide conjugates adjuvanted with 3D-MPL and substantially devoid of aluminium-based adjuvant.
摘要翻译: 本发明涉及细菌多糖抗原疫苗领域。 特别地,本发明涉及用3D-MPL佐剂化并且基本上不含铝基佐剂的特定有利的肺炎球菌多糖缀合物。
-
公开(公告)号:US06106842A
公开(公告)日:2000-08-22
申请号:US513768
申请日:1995-08-29
申请人: Carine Capiau , Martin Comberbach , Piet Roelants , Jean Petre
发明人: Carine Capiau , Martin Comberbach , Piet Roelants , Jean Petre
IPC分类号: C12P21/00 , A61K39/00 , A61K39/10 , A61P31/04 , C07K1/14 , C07K14/235 , C07K14/705 , C12N1/02 , C12R1/01 , A61K39/02 , C12P1/00
CPC分类号: C07K14/235 , C12N1/02 , A61K39/00 , Y10S530/82 , Y10S530/825
摘要: The present invention discloses a process for extracting a cell-bound protein of bacterial origin, useful in acellular vaccines, comprising contacting a suspension of the cell-bound protein with a flocculating agent prior to heat treatment.
摘要翻译: PCT No.PCT / EP94 / 00597 371日期1995年10月23日第 102(e)日期1995年10月23日PCT 1994年2月28日PCT PCT。 公开号WO94 / 20538 日期1994年9月15日本发明公开了一种提取细菌来源的细胞结合蛋白的方法,可用于脱细胞疫苗,包括在热处理前将细胞结合蛋白的悬浮液与絮凝剂接触。
-
公开(公告)号:US08926985B2
公开(公告)日:2015-01-06
申请号:US12612988
申请日:2009-11-05
申请人: Carine Capiau , Marguerite Deschamps , Pierre Michel Desmons , Craig Antonyjoseph Laferriere , Jan Poolman , Jean-Paul Prieels
发明人: Carine Capiau , Marguerite Deschamps , Pierre Michel Desmons , Craig Antonyjoseph Laferriere , Jan Poolman , Jean-Paul Prieels
IPC分类号: A61K39/385 , A61K39/116 , A61K39/00 , A61K39/02 , A61K39/09 , A61K39/102 , A01N43/04 , C07H1/00 , A61K39/095 , A61K39/155
CPC分类号: A61K47/4833 , A61K39/092 , A61K39/095 , A61K39/102 , A61K39/12 , A61K39/155 , A61K47/646 , A61K2039/55505 , A61K2039/55572 , A61K2039/6037 , A61K2039/6068 , A61K2039/6075 , A61K2039/70 , Y02A50/414 , Y02A50/484 , Y10S424/831
摘要: The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to bacterial polysaccharides conjugated to protein D from H. influenzae.
-
公开(公告)号:US20130171188A1
公开(公告)日:2013-07-04
申请号:US13778633
申请日:2013-02-27
申请人: Ralph Leon BIEMANS , Dominique BOUTRIAU , Carine CAPIAU , Philippe DENOEL , Pierre DUVIVIER , Jan POOLMAN
发明人: Ralph Leon BIEMANS , Dominique BOUTRIAU , Carine CAPIAU , Philippe DENOEL , Pierre DUVIVIER , Jan POOLMAN
IPC分类号: A61K39/29 , A61K39/05 , A61K39/095 , A61K39/02 , A61K39/102 , A61K39/09 , A61K39/08
CPC分类号: A61K39/385 , A61K39/0017 , A61K39/0018 , A61K39/05 , A61K39/08 , A61K39/092 , A61K39/095 , A61K39/099 , A61K39/102 , A61K39/116 , A61K39/12 , A61K39/145 , A61K39/292 , A61K2039/545 , A61K2039/55 , A61K2039/575 , A61K2039/6037 , A61K2039/62 , A61K2039/627 , A61K2039/70 , C07H3/00 , C12N7/00 , C12N2730/10134 , C12N2760/16234 , C12N2760/16271 , C12N2770/32634 , Y02A50/466 , Y02A50/472 , Y02A50/484
摘要: The present application discloses an immunogenic composition comprising a Hib saccharide conjugate, at least one additional bacterial, for example N. meningitidis, saccharide conjugate(s), and a further antigen selected from the group consisting of whole cell pertussis and hepatitis B surface antigen, wherein the saccharide dose of the Hib saccharide conjugate is less than 5 μg.
摘要翻译: 本申请公开了一种免疫原性组合物,其包含Hib糖结合物,至少一种额外的细菌,例如脑膜炎奈瑟球菌,糖结合物和选自全细胞百日咳和乙型肝炎表面抗原的另外的抗原, 其中Hib糖共轭物的糖剂量小于5杯。
-
公开(公告)号:US20090041802A1
公开(公告)日:2009-02-12
申请号:US11917610
申请日:2006-06-23
申请人: Ralph Leon Biemans , Dominique Boutriau , Carine Capiau , Philippe Denoel , Pierre Devivier , Jan Poolman
发明人: Ralph Leon Biemans , Dominique Boutriau , Carine Capiau , Philippe Denoel , Pierre Devivier , Jan Poolman
IPC分类号: A61K39/385 , A61P31/04 , A61P31/12
CPC分类号: A61K39/385 , A61K39/0017 , A61K39/0018 , A61K39/05 , A61K39/08 , A61K39/092 , A61K39/095 , A61K39/099 , A61K39/102 , A61K39/116 , A61K39/12 , A61K39/145 , A61K39/292 , A61K2039/545 , A61K2039/55 , A61K2039/575 , A61K2039/6037 , A61K2039/62 , A61K2039/627 , A61K2039/70 , C07H3/00 , C12N7/00 , C12N2730/10134 , C12N2760/16234 , C12N2760/16271 , C12N2770/32634 , Y02A50/466 , Y02A50/472 , Y02A50/484
摘要: The present application discloses an immunogenic composition comprising N. meningitidis capsular polysaccharides from at least one of serogroups A, C, W135 and Y conjugated to a carrier protein to produce a N. meningitidis capsular polysaccharide conjugate, wherein the average size of each N. meningitidis polysaccharide is above 50 kDa.
摘要翻译: 本申请公开了一种免疫原性组合物,其包含来自与载体蛋白缀合的血清群A,C,W135和Y中的至少一种的脑膜炎奈瑟氏球菌荚膜多糖以产生脑膜炎奈瑟氏球菌荚膜多糖缀合物,其中每个脑膜炎奈瑟氏球菌的平均大小 多糖超过50kDa。
-
公开(公告)号:US20080069835A1
公开(公告)日:2008-03-20
申请号:US11853108
申请日:2007-09-11
CPC分类号: A61K39/0018 , A61K39/092 , A61K39/095 , A61K39/102 , A61K39/12 , A61K39/13 , A61K39/29 , A61K39/292 , A61K2039/5252 , A61K2039/55505 , A61K2039/55583 , A61K2039/6037 , A61K2039/70 , C12N2730/10134 , C12N2770/32634 , Y02A50/464 , Y02A50/466 , Y02A50/484
摘要: The present invention relates to new, advantageous DTP-based combination vaccine formulations, and concomitantly administered combination vaccine kits. Methods of administration of these vaccines and kits are also provided.
摘要翻译: 本发明涉及新的,有利的基于DTP的组合疫苗制剂和伴随施用的组合疫苗试剂盒。 还提供了这些疫苗和试剂盒的给药方法。
-
-
-
-
-
-
-
-
-